U.S. flag An official website of the United States government
  1. Home
  2. Drugs
  3. Drug Safety and Availability
  4. Drug Recalls
  1. Drug Safety and Availability

A drug recall is the most effective way to protect the public from a defective or potentially harmful product. A recall is a voluntary action taken by a company to remove a defective drug product from the market or warn patients and consumers about a potential risk.

The list below includes voluntary drug recalls in which public notification has been issued.

Visit FDA’s role in drug recalls for more information.
Visit Recalls, Market Withdrawals, & Safety Alerts for all FDA-regulated products.
Follow FDA Recall Information on X (formerly Twitter).



A Terminated Recall is a recall where the FDA has determined that all reasonable efforts have been made to remove or correct the violative product in accordance with the recall strategy, and proper disposition has been made according to the degree of hazard. Recalls that are not indicated as being terminated are either ongoing or completed.

Date Brand Name(s) Product Description Recall Reason Description Company Name Terminated Recall Excerpt
Rugby OTC Ophthalmic Sterile Drops Insanitary manufacturing conditions The Harvard Drug Group, LLC dba Major Pharmaceutical and Rugby Laboratories
LEADER OTC Ophthalmic Sterile Drops Insanitary manufacturing conditions Cardinal Health, Inc.
Exela and Civica Brands Sodium Bicarbonate Injection, USP, Midazolam in 0.8% Sodium Chloride Injection ELCYS (cysteine hydrochloride Injection), USP Potential presence of particulate matter Exela Pharma Sciences, LLC
Multiple brands Dietary Supplements with undeclared Diclofenac Undeclared drug, Diclofenac Botanical-Be
Multiple brands Over-the-Counter Drug and Medical Device products Products were stored outside of labeled temperature requirements Family Dollar
KVK Tech Betaxolol Tablets, USP Potential Presence of Oxycodone HCl tablet KVK-Tech, Inc.
Hospira 4.2% Sodium Bicarbonate Injection, USP, 1% Lidocaine HCl Injection, USP, and 2% Lidocaine HCl Injection, USP Potential Presence of Glass Particulates Hospira, Inc.
Ion and Restore brands Nasal Sprays Potential Contamination with Microbacterium spp., Fictibacillus spp., Bacillus spp., and Paenibacillus spp. Biomic Sciences
Brexafemme Antifungal oral medication Potential cross contamination with non-antibacterial beta-lactam drug substance Scynexis, Inc.
VistaPharm Sucralfate Oral Suspension 1g/10mL Potential contamination with Bacillus cereus Potential contamination with Bacillus cereus
Back to Top